Application: pharmacological profile similar to that of enobosarm, Ostarine,MK-2866 investigational selective androgen receptor modulator (SARM) for treatment of conditions such as muscle wasting and osteoporosis
Appearance: White crystalline powder
Pharmacological profile similar to that of enobosarm, Ostarine,MK-2866
Investigational selective androgen receptor modulator (SARM) for treatment of conditions such as muscle wasting and osteoporosis
Improve your own testosterone utilization rate, reduce body fat content while increasing lean body mass.
How it works?
LGD-4033, a novel nonsteroidal, oral selective androgen receptor modulator, binds to the androgen receptor with high affinity and selectivity. It demonstrates anabolic activity in muscles, anti-resorptive and anabolic activity in bones and a robust selectivity for muscle and bone versus prostate and sebaceous glands. LGD-4033 has recently completed a Phase I Multiple Ascending Dose study in healthy volunteers.
Dosages and Suggestion：
Recommended maximum dose LIGANDROL the safety and tolerability up to doses of 22 mg -25mg . It has a half-life of 24 hours a day.
|Appearance||white to off-white powder||pass|
|Identification||The retention time of the major peak |
isconfirm to the RS
|Loss on Drying||Not more than 0.5%||0.33%|
|Assay(HPLC)||Not less than 98.0%||99.28%|
|Ignition residue||Not more than 0.1%||pass|
|Heavy metal||Not more than 20 ppm||pass|